Epipen’s $69 Cost in U.K. Shows Other Extreme of Drug Pricing

Sept. 30, 2016, 4:00 AM UTC

The EpiPen allergy shot, enmeshed in controversy because it sells for almost as much as the latest iPhone in the U.S., costs less than its leather case in Britain.

The price of an EpiPen two-pack has surged to more than $600 in the U.S., sparking a political outcry. While the manufacturer, Mylan NV, says it takes home about $274, in the U.K. a similar pair of injectors costs the state-funded National Health Service 53 pounds ($69). The numbers highlight the stark differences in the way drugs are priced in the U.S. and Britain, where the government negotiates with pharmaceutical companies ...

Learn more about Bloomberg Law or Log In to keep reading:

See Breaking News in Context

Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.

Already a subscriber?

Log in to keep reading or access research tools and resources.